Theriva Biologics (TOVX) Other Non-Current Assets (2010 - 2026)
Theriva Biologics' Other Non-Current Assets came in at $80,000 for Q2 2026, down 2.4% from $82,000 a year earlier and down 1.2% from the prior quarter.
Powered by 
Analysis
Theriva Biologics (TOVX) Other Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Theriva Biologics' Other Non-Current Assets was $82,000, down 14.6% from FY2024.
- Other Non-Current Assets carries a five-year compound annual growth rate of 28.9% (FY2020 to FY2025).
- Going back by year, Other Non-Current Assets was $96,000 in FY2024 (-5.9%), $102,000 in FY2023 (+3.0%), $99,000 in FY2022 (+330.4%) and $23,000 in FY2021 (unchanged).
- The Q2 2026 figure represents the lowest quarterly Other Non-Current Assets since Q1 2022.
- Year-over-year, Other Non-Current Assets has declined for five consecutive quarters, with an average decline of 9.0% over the last eight quarters.
- The fastest year-over-year change in Other Non-Current Assets over five years came in Q1 2023 (growth of 334.8%), and the weakest in Q3 2025 (a decline of 20.4%).
- Business Quant data shows TOVX's Other Non-Current Assets at $81,000 (Q1 2026), $82,000 (Q4 2025) and $82,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Theriva Biologics | 10.56 Mn | 10.56 Mn | - | 80,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 80,000.00 |
| Mar 31, 2026 | 81,000.00 |
| Dec 31, 2025 | 82,000.00 |
| Sep 30, 2025 | 82,000.00 |
| Jun 30, 2025 | 82,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 96,000.00 |
| Sep 30, 2024 | 103,000.00 |
| Jun 30, 2024 | 99,000.00 |
| Mar 31, 2024 | 99,000.00 |
| Dec 31, 2023 | 102,000.00 |
| Sep 30, 2023 | 97,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Dec 31, 2022 | 99,000.00 |
| Sep 30, 2022 | 90,000.00 |
| Jun 30, 2022 | 96,000.00 |
| Mar 31, 2022 | 23,000.00 |
| Dec 31, 2021 | 23,000.00 |
| Sep 30, 2021 | 23,000.00 |
API Access
Theriva Biologics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=TOVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "TOVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=TOVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();